<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate differences in clinical appearance and survival rates in patients operated on for <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in the distal esophagus with and without <z:e sem="disease" ids="C1258085" disease_type="Disease or Syndrome" abbrv="">Barrett epithelium</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Prospective clinical study </plain></SENT>
<SENT sid="2" pm="."><plain>SETTING: University hospital, Sweden </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENTS: Fifty-four patients with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in the distal esophagus with (n = 17) or without (n = 37) <z:e sem="disease" ids="C1258085" disease_type="Disease or Syndrome" abbrv="">Barrett epithelium</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>INTERVENTION: Esophagectomy or total gastrectomy </plain></SENT>
<SENT sid="5" pm="."><plain>MAIN OUTCOME MEASURES: Preoperative symptoms, endoscopic results, and histological findings; postoperative morbidity, mortality, and survival rates </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The main indication for the endoscopic examination that revealed <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> in the group with <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> was reflex-related symptoms in 6 patients (routine Barrett examination, n = 4; symptoms of reflux, n = 2), symptoms related to upper gastrointestinal tract <z:mp ids='MP_0001914'>bleeding</z:mp> in 6, and malignant symptoms in 5 (<z:hpo ids='HP_0002015'>dysphagia</z:hpo>, n = 4; <z:hpo ids='HP_0001824'>weight loss</z:hpo>, n = 1) </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, most patients in the cardia <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> group were admitted because of malignant symptoms (<z:hpo ids='HP_0002015'>dysphagia</z:hpo>, n = 26; epigastric pain, n = 9; and <z:hpo ids='HP_0001903'>anemia</z:hpo>, n = 2) </plain></SENT>
<SENT sid="8" pm="."><plain>Ten of 17 patients in the <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> group had <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> limited to the mucosa and submucosa only </plain></SENT>
<SENT sid="9" pm="."><plain>In 1 patient the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> grew into the muscular layer but not through it </plain></SENT>
<SENT sid="10" pm="."><plain>In the remaining 6 patients the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> did grow through the muscular layer and <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> were found </plain></SENT>
<SENT sid="11" pm="."><plain>Wall penetration was found in 30 patients and <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">metastases to lymph nodes</z:e> in 29 patients in the cardia <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> group </plain></SENT>
<SENT sid="12" pm="."><plain>The hospital mortality rate was 0 of 17 patients in the Barrett <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> group and 2 of 37 patients in the cardia <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> group </plain></SENT>
<SENT sid="13" pm="."><plain>In the patients operated on for <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in the distal esophagus, a better long-term survival rate was seen in those with <z:e sem="disease" ids="C1258085" disease_type="Disease or Syndrome" abbrv="">Barrett epithelium</z:e> (50%) than in those without this <z:mpath ids='MPATH_160'>metaplasia</z:mpath> (10%) (log rank P = .005; X2 = 7.80) </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: Concomitant <z:e sem="disease" ids="C1258085" disease_type="Disease or Syndrome" abbrv="">Barrett epithelium</z:e> improved the prognosis for patients with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in the distal esophagus </plain></SENT>
<SENT sid="15" pm="."><plain>Probably the reason for this was a higher rate of early-stage disease, because symptoms of <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> and other benign disorders, not <z:hpo ids='HP_0002015'>dysphagia</z:hpo>, were most common in patients with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> without <z:e sem="disease" ids="C1258085" disease_type="Disease or Syndrome" abbrv="">Barrett epithelium</z:e> in the distal esophagus </plain></SENT>
</text></document>